Market Overview
The electroretinogram market includes diagnostic instruments and consumables used to record retinal electrical responses to visual stimuli, providing objective functional assessment of photoreceptor and retinal ganglion cells. In 2025, the market is valued at approximately $0.062 billion, though published estimates for this niche sector vary considerably depending on whether scopes include related visual electrophysiology products. No official government statistical agency publishes dedicated market size figures specifically for ERG systems, so available sizing data comes from private analyst estimates.
- •Market valued at approximately $62 million in 2025, with estimates varying across research sources
- •Primarily serves ophthalmology clinics, hospitals, and vision research institutions
- •Includes full-field ERG, multi-focal ERG, pattern ERG, and portable handheld variants
Growth Drivers
The rising global burden of retinal disorders, including diabetic retinopathy, age-related macular degeneration, and inherited retinal dystrophies, is the primary force propelling market expansion. An aging worldwide population, combined with increased prevalence of diabetes and prolonged screen exposure, is expanding the patient population requiring retinal functional testing. Technological improvements such as portable ERG systems, better electrode designs, and electronic medical record integration are lowering barriers to adoption and enabling broader clinical use.
- •Growing prevalence of diabetes and age-related eye diseases increases demand for ERG diagnostic testing
- •Aging global demographics expand the at-risk population for retinal conditions
- •Advances in portable and non-invasive ERG technology support adoption across diverse clinical settings
Segmentation and Regional Analysis
The market is segmented by product type, including full-field ERG, multi-focal ERG, pattern ERG, and handheld systems, with full-field ERG remaining the most widely used for comprehensive retinal functional assessment across both clinical and research applications. North America and Europe currently account for the largest combined market share due to established healthcare infrastructure, higher diagnostic rates, and concentration of key manufacturers. The Asia-Pacific region is expected to exhibit the fastest growth, while Latin America and the Middle East show gradual adoption as ophthalmic services expand.
- •North America and Europe hold the largest combined market share currently
- •Asia-Pacific is projected as the fastest-growing regional market
- •Product segments include full-field ERG, multi-focal ERG, pattern ERG, and portable systems
Trends and Outlook
What are the recent trends and outlook?
Miniaturization and the development of handheld ERG devices represent a significant trend, enabling point-of-care testing and expanding access beyond traditional hospital laboratories to primary care and specialist offices. Integration of artificial intelligence and cloud-based data management platforms is emerging to support automated signal analysis, improved diagnostic consistency, and remote data sharing. Over the medium term, the market is expected to continue steady expansion as clinical guidelines evolve and emerging markets increase their ophthalmology infrastructure investments.
- •Handheld and portable ERG devices are expanding testing beyond specialized centers
- •Integration of AI-based analysis tools is improving diagnostic speed and consistency
- •Market projected to continue steady growth through the early 2030s across all major regions
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.